Oakes A

No ORCID on file · 1 paper in corpus
2022
Annals of internal medicine ·doi:10.7326/m22-1329

BackgroundMonoclonal antibody (mAb) treatment decreases hospitalization and death in high-risk outpatients with mild to moderate COVID-19. However, no studies have evaluated adverse events and effectiveness of mAbs in pregnant persons compa…